FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Saturday

 

Vitamin D supplementation may decrease seasonal relapse rate among MS patients




























A study published by the journal, Brain and Behavior, found that MS patients who supplemented with vitamin D during the winter and spring months experienced a 50% decrease in relapses annually.

MS is a chronic disease in which the body’s immune system begins attacking the protective sheath covering the nerve cells in the brain and spinal cord. Damage to these cells causes an interference of nerve signals between the brain, spinal cord and body.

Symptoms of MS include, but are not limited to, numbness and tingling, muscle spasms, pain, impaired physical coordination, blurred vision and fatigue. Severe cases may leave patients unable to walk or drive, potentially affecting their ability to work or carry out activities of daily living.

The most common type of MS is called relapsing remitting multiple sclerosis (RRMS). This form of MS is characterized by periods of increased disease activity, or relapse, followed by periods where some or all of the symptoms disappear, known as remission. Interestingly, MS relapses most frequently appear during the late winter and early spring months, a time when sun exposure is less intense, and vitamin D production decreases substantially.

Therefore, researchers have become interested in the role of vitamin D in MS outcome. Evidence is continuing to strengthen this relationship, with researching showing maternal vitamin D deficiency is linked with a nearly 2-fold increased risk of the offspring developing MS later in life. Additionally, both sun exposure and vitamin D supplementation are associated with disease outcome of MS.

However, until now, researchers have yet to evaluate the effect of vitamin D supplementation on the relationship between seasonal variations in UVB radiation, vitamin D status and MS relapse rate. Therefore, in this study, researchers hypothesized that supplementing with vitamin D during the winter and early spring, when vitamin D production drops, would decrease the rate of relapse among MS patients.

The researchers analyzed the medical records of MS patients between April 2010 and June 2016 at the neurological outpatient department Neurocenter Peine, in Germany. Individuals were included in the analysis if they met the following criteria: at least 6 months of care without vitamin D supplementation, and 6 months of care with weekly vitamin D supplementation of about 20,000 IU. A total of 40 patients met this criteria, and thus were included in the analysis.

The patients had their vitamin D levels measured two years after beginning their supplementation regimen. UVB radiation data was provided by the local government. The researchers observed the patients quarterly and annual relapse rate prior to and during vitamin D supplementation.

Here is what the researchers found:
  • The patients supplemented with an average of 18,950 IU (474 mcg) vitamin D3 per week.
  • Prior to supplementation, patients experienced seasonal variations of 25(OH)D status, with vitamin D levels peaking from July to September and lowest between January and March.
  • The only time that non supplemented patients reached levels above than 20 ng/ml (51 nmol/l) was between July and September.
  • Serum vitamin D levels increased by 20 ng/ml (51 nmol/l) after supplementing with vitamin D for 6 months (p < 0.001).
  • Vitamin D supplementation prevented significant drops in vitamin D levels during the winter and spring months (p > 0.05), with vitamin D levels maintaining around 28 ng/ml (70 nmol/l).
  • Vitamin D was associated with a 50% decrease in MS annual relapse rate (p = 0.04).
  • The annual decrease in relapse was largely attributed to the reduction in quarterly relapse rate during the late winter and early spring months.
  • The researchers concluded,
“Our study demonstrated the modulation of seasonal MS disease activity through vitamin D supplementation.”

Story Source: The above story is based on materials provided by VITAMINDCOUNCIL
Note: Materials may be edited for content and length
Click here to read more

Labels: ,



Go to Newer News Go to Older News